Cargando…

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment

Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI) are closely associated with Tau proteins accumulation. In this study, we aimed to implement radiomics analysis to discover high-order features from pathological biomarker and improve the classification accuracy based on Tau PET images. Two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Fangyang, Wang, Min, Sun, Xiaoming, Ju, Zizhao, Lu, Jiaying, Wang, Luyao, Jiang, Jiehui, Zuo, Chuantao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953966/ https://www.ncbi.nlm.nih.gov/pubmed/36831910 http://dx.doi.org/10.3390/brainsci13020367

Ejemplares similares

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
por: Zhou, Hucheng, et al.
Publicado: (2019)

Combining PET with MRI to improve predictions of progression from mild cognitive impairment to Alzheimer’s disease: an exploratory radiomic analysis study
por: Yang, Fan, et al.
Publicado: (2022)

In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer’s Disease: A (18)F-Florzolotau Study
por: Ju, Zizhao, et al.
Publicado: (2022)

Radiomics: a novel feature extraction method for brain neuron degeneration disease using (18)F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment
por: Li, Yupeng, et al.
Publicado: (2019)

Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images
por: Shen, Ting, et al.
Publicado: (2019)

A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment
por: Wang, Min, et al.
Publicado: (2020)

Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [(18)F]-APN-1607 Study
por: Zhang, Huiwei, et al.
Publicado: (2021)

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2019)

Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer’s dementia
por: Wang, Min, et al.
Publicado: (2020)

The Parkinson's Disease Progression Neuroimaging Initiative
por: Zhu, Shiyi, et al.
Publicado: (2021)

Associations of [(18)F]-APN-1607 Tau PET Binding in the Brain of Alzheimer’s Disease Patients With Cognition and Glucose Metabolism
por: Lu, Jiaying, et al.
Publicado: (2020)

Radiomic Features of Hippocampal Subregions in Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
por: Feng, Feng, et al.
Publicado: (2018)

Brain Network and Abnormal Hemispheric Asymmetry Analyses to Explore the Marginal Differences in Glucose Metabolic Distributions Among Alzheimer's Disease, Parkinson's Disease Dementia, and Lewy Body Dementia
por: Chen, Danyan, et al.
Publicado: (2019)

A Novel Deep Learning Radiomics Model to Discriminate AD, MCI and NC: An Exploratory Study Based on Tau PET Scans from ADNI †
por: Zhao, Yan, et al.
Publicado: (2022)

Optimized Cingulate Island Sign in Discriminating Dementia With Lewy Bodies From Alzheimer Disease
por: Ge, Jingjie, et al.
Publicado: (2023)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
por: Rubinski, Anna, et al.
Publicado: (2020)

Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer's Disease or Mild Cognitive Impairment
por: Li, Lanlan, et al.
Publicado: (2021)

Estimation of Tau and Phosphorylated Tau(181) in Serum of Alzheimer’s Disease and Mild Cognitive Impairment Patients
por: Shekhar, Shashank, et al.
Publicado: (2016)

International consensus on the use of tau PET imaging agent (18)F-flortaucipir in Alzheimer’s disease
por: Tian, Mei, et al.
Publicado: (2022)

Deep learning detection of informative features in tau PET for Alzheimer’s disease classification
por: Jo, Taeho, et al.
Publicado: (2020)

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Study of the Influence of Age in (18)F-FDG PET Images Using a Data-Driven Approach and Its Evaluation in Alzheimer's Disease
por: Jiang, Jiehui, et al.
Publicado: (2018)

Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease
por: Johansson, Maurits, et al.
Publicado: (2021)

Generative adversarial network constrained multiple loss autoencoder: A deep learning‐based individual atrophy detection for Alzheimer's disease and mild cognitive impairment
por: Shi, Rong, et al.
Publicado: (2022)

Prediction of the progression from mild cognitive impairment to Alzheimer’s disease using a radiomics-integrated model
por: Shu, Zhen-Yu, et al.
Publicado: (2021)

PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research
por: Bao, Weiqi, et al.
Publicado: (2021)

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
por: Guo, Yu, et al.
Publicado: (2021)

Deep-Learning Radiomics for Discrimination Conversion of Alzheimer's Disease in Patients With Mild Cognitive Impairment: A Study Based on (18)F-FDG PET Imaging
por: Zhou, Ping, et al.
Publicado: (2021)

The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s disease
por: Lu, Jiaying, et al.
Publicado: (2023)

Monitoring Alzheimer’s Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods
por: Beheshti, Iman, et al.
Publicado: (2022)

Unlocking the enigma: unraveling multiple cognitive dysfunction linked to glymphatic impairment in early Alzheimer’s disease
por: Zhong, Jiayi, et al.
Publicado: (2023)

Longitudinal tau PET in ageing and Alzheimer’s disease
por: Jack, Clifford R, et al.
Publicado: (2018)

Quality Reporting of Radiomics Analysis in Mild Cognitive Impairment and Alzheimer's Disease: A Roadmap for Moving Forward
por: Won, So Yeon, et al.
Publicado: (2020)

Quantitative (18)F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients
por: Zhao, Qian, et al.
Publicado: (2019)

A metabolism‐functional connectome sparse coupling method to reveal imaging markers for Alzheimer's disease based on simultaneous PET/MRI scans
por: Wang, Luyao, et al.
Publicado: (2023)

Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints
por: Lu, Jiaying, et al.
Publicado: (2023)

Improved interpretation of (18)F-florzolotau PET in progressive supranuclear palsy using a normalization-free deep-learning classifier
por: Lu, Jiaying, et al.
Publicado: (2023)

Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [(18)F]Florzolotau PET imaging and subtype/stage inference algorithm
por: Hong, Jimin, et al.
Publicado: (2023)

Plasma tau proteins for the diagnosis of mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis
por: Chen, Leian, et al.
Publicado: (2022)

A novel individual-level morphological brain networks constructing method and its evaluation in PET and MR images
por: Jiang, Jiehui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i5fue9hm2n4l8448213up51dnj